Another factor of interest is the nuclear transcription factor, NF-kappa B. NF-κB was originally identified in B cells, contributes to marginal zone B cell formation, and is often constitutively activated in numerous inflammatory conditions and human cancers, including B cell lymphomas [59], [60]. The gene discussed is NFKB1; the disease is B-cell non-Hodgkin lymphoma.